Quantitative Systematic Strategies’s Salix Pharmaceuticals SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-14,266
Closed -$2.22M – 494
2014
Q3
$2.22M Buy
14,266
+9,495
+199% +$1.38M 1.29% 2
2014
Q2
$586K Buy
+4,771
New +$527K 0.42% 93

Other funds holding SLXP

Quantitative Systematic Strategies's SLXP Position: Q4 2014 in Review

Quantitative Systematic Strategies sold out of Salix Pharmaceuticals (SLXP) in Q4 2014, closing a stake of 14,266 shares — an estimated $2.22M sold.

Quantitative Systematic Strategies first reported a position in SLXP in Q2 2014 and held it in 2 quarters. The position peaked at $2.22M in Q3 2014. 347 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Quantitative Systematic Strategies reported no remaining Salix Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,266 Salix Pharmaceuticals shares in Q4 2014, an estimated $2.22M.
  • Quantitative Systematic Strategies first reported a position in Salix Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Salix Pharmaceuticals position peaked at $2.22M in Q3 2014.
  • 347 funds tracked by Wall St. Rank held Salix Pharmaceuticals as of Q4 2014.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2014, filed 21 Jan 2015.